HJLI - Hancock Jaffe Laboratories, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 512.55M
Enterprise Value 310.52M
Trailing P/E N/A
Forward P/E 1-1.71
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)203.31
Price/Book (mrq)4.07
Enterprise Value/Revenue 3170.51
Enterprise Value/EBITDA 6-1.56

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-54.84%
S&P500 52-Week Change 321.24%
52 Week High 33.4500
52 Week Low 30.3800
50-Day Moving Average 30.5803
200-Day Moving Average 30.7019

Share Statistics

Avg Vol (3 month) 386.89k
Avg Vol (10 day) 387.65k
Shares Outstanding 517.92M
Float 12.81M
% Held by Insiders 126.31%
% Held by Institutions 11.59%
Shares Short (Jan 30, 2020) 4146k
Short Ratio (Jan 30, 2020) 41.19
Short % of Float (Jan 30, 2020) 41.04%
Short % of Shares Outstanding (Jan 30, 2020) 40.81%
Shares Short (prior month Dec 30, 2019) 4183.55k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-11,110.30%

Management Effectiveness

Return on Assets (ttm)-76.60%
Return on Equity (ttm)-214.79%

Income Statement

Revenue (ttm)61.7k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)186.55k
EBITDA -6.74M
Net Income Avi to Common (ttm)-7.12M
Diluted EPS (ttm)-0.5010
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.94M
Total Cash Per Share (mrq)0.16
Total Debt (mrq)922.94k
Total Debt/Equity (mrq)29.93
Current Ratio (mrq)1.52
Book Value Per Share (mrq)0.17

Cash Flow Statement

Operating Cash Flow (ttm)-5.72M
Levered Free Cash Flow (ttm)-3.38M